Clinicopathologic association of cyclooxygenase 1 and cyclooxygenase 2 expression in gastric adenocarcinoma.
about
Cyclooxygenase-2 and gastric carcinogenesisThe influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer.Celecoxib: a specific COX-2 inhibitor with anticancer properties.MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer.Helicobacter pylori VacA enhances prostaglandin E2 production through induction of cyclooxygenase 2 expression via a p38 mitogen-activated protein kinase/activating transcription factor 2 cascade in AZ-521 cells.Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma.Non-steroidal anti-inflammatory drugs in prevention of gastric cancer.Evaluation of the Role of ALDH1 as Cancer Stem Cell Marker in Colorectal Carcinoma: An Immunohistochemical Study.Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention.Cyclooxygenase-2 expression is associated with poor overall survival of patients with gastric cancer: a meta-analysis.Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques.Sinomenine inhibits proliferation of SGC-7901 gastric adenocarcinoma cells via suppression of cyclooxygenase-2 expression.Late administration of a specific COX-2 inhibitor does not treat and/or prevent progression of gastric tumors in rats submitted to duodenogastric reflux procedure.
P2860
Q28184447-729F4586-AE9A-4352-AE5B-F0218A6F8536Q34274752-288437C0-6818-47AB-8ED0-16F06A672BE0Q34608635-BC8F3AD2-0D86-41B7-8ED0-AD874431A8F3Q35770018-623E29AB-CE40-45E0-843A-48DC1710A49AQ35947228-7E2097A6-C45B-4DE7-9068-44FD4E496FADQ36190616-A9B92972-E4E3-470C-A060-A650C9E7428BQ36485784-94F8B08B-6B5D-4376-891B-AD7ADA7A919DQ37663625-2F69F9BC-724F-4CDC-A50F-6AA6D1A6BB58Q37963769-E3D7D3B1-CFD3-46C4-88EE-7E5226E3FC73Q38157778-BCCABE36-3BBA-4C51-8EF3-9194D548A7EFQ38439688-D7F2D009-A092-49C1-8356-7485405F42A6Q42251992-3C6C4835-4408-48BE-A079-6B977FB65E93Q48229709-BD787829-CF5D-4645-85B9-439F3C57B8D9
P2860
Clinicopathologic association of cyclooxygenase 1 and cyclooxygenase 2 expression in gastric adenocarcinoma.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Clinicopathologic association ...... ion in gastric adenocarcinoma.
@en
Clinicopathologic association ...... ion in gastric adenocarcinoma.
@nl
type
label
Clinicopathologic association ...... ion in gastric adenocarcinoma.
@en
Clinicopathologic association ...... ion in gastric adenocarcinoma.
@nl
prefLabel
Clinicopathologic association ...... ion in gastric adenocarcinoma.
@en
Clinicopathologic association ...... ion in gastric adenocarcinoma.
@nl
P2093
P2860
P1433
P1476
Clinicopathologic association ...... ion in gastric adenocarcinoma.
@en
P2093
P2860
P304
P356
10.1097/00000658-200102000-00006
P407
P577
2001-02-01T00:00:00Z